Ozone Therapy as a Treatment for Low Back Pain Secondary to Herniated Disc: A Systematic Review and Meta-analysis of Randomized Controlled Trials

Show simple item record

dc.contributor Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.author MAGALHAES, Francisco N. De Oliveira FMUSP-HC
DOTTA, Luciana FMUSP-HC
SASSE, Andre
TEIXEIRA, Manoel J. FMUSP-HC
FONOFF, Erich T. FMUSP-HC
dc.date.issued 2012
dc.identifier.citation PAIN PHYSICIAN, v.15, n.2, p.E115-E129, 2012
dc.identifier.issn 1533-3159
dc.identifier.uri http://observatorio.fm.usp.br/handle/OPI/772
dc.description.abstract Background: Low back pain (LBP) is one of the most common and important health problems affecting the population worldwide and remains mostly unsolved. Ozone therapy has emerged as an additional treatment method. Questions persist concerning its clinical efficacy. Objective: The purpose of our study was to evaluate the therapeutic results of percutaneous injection of ozone for low back pain secondary to disc herniation. Study Design: A systematic review and meta-analysis of randomized controlled trials. Methods: A comprehensive literature search was conducted using all electronic databases from 1966 through September 2011. The quality of individual articles was assessed based on the modified Cochrane review criteria for randomized trials and criteria from the Agency for Healthcare Research and Quality. Outcome Parameters: The outcome measure was short-term pain relief of at least 6 months or long-term pain relief of more than 6 months. Results: Eight observational studies were included in the systematic review and 4 randomized trials in the meta-analysis. The indicated level of evidence for long-term pain relief was II-3 for ozone therapy applied intradiscally and II-1 for ozone therapy applied paravertebrally. The grading of recommendation was 1C for intradiscal ozone therapy and 1B for paravertebral ozone therapy. Limitations: The main limitations of this review are the lack of precise diagnosis and the frequent use of mixed therapeutic agents. The meta-analysis included mainly active-control trials. No placebo-controlled trial was found. Conclusions: Ozone therapy appears to yield positive results and low morbidity rates when applied percutaneously for the treatment of chronic low back pain.
dc.description.sponsorship · FAPESP [2011/08529-5]
dc.language.iso eng
dc.publisher AM SOC INTERVENTIONAL PAIN PHYSICIANS
dc.relation.ispartof Pain Physician
dc.rights openAccess
dc.subject Low back pain; ozone therapy; chronic pain; failed back surgery syndrome
dc.subject.other oxygen-ozone; lumbar disc; intraforaminal o-2-o-3; injection; guidelines; sciatica; management
dc.title Ozone Therapy as a Treatment for Low Back Pain Secondary to Herniated Disc: A Systematic Review and Meta-analysis of Randomized Controlled Trials
dc.type article
dc.rights.holder Copyright AM SOC INTERVENTIONAL PAIN PHYSICIANS
dc.description.group LIM/26
dc.identifier.pmid 22430658
dc.type.category review
dc.type.version publishedVersion
hcfmusp.author MAGALHAES, Francisco N. De Oliveira:FM:
hcfmusp.author DOTTA, Luciana:HC:IOT
hcfmusp.author TEIXEIRA, Manoel J.:FM:MNE
hcfmusp.author FONOFF, Erich T.:HC:IPQ
hcfmusp.origem.id WOS:000301917800001
hcfmusp.origem.id 2-s2.0-84859120791
hcfmusp.publisher.city PADUCAH
hcfmusp.publisher.country USA
hcfmusp.relation.reference · Andreula CF, 2003, AM J NEURORADIOL, V24, P996
· Ansede Alonso JC, 2007, PATOLOGIA APARATO LO, V5, P46
· Berg AO, 2001, AM J PREV MED, V20, P21
· Bocci VA, 2006, ARCH MED RES, V37, P425, DOI 10.1016/j.arcmed.2005.08.006
· Bonetti M, 2005, AM J NEURORADIOL, V26, P996
· Buric J, 2005, ACT NEUR S, V92, P93
· Chalaupka FD, 2007, HEADACHE, V47, P293
· Cohen SP, 2005, J SPINAL DISORD TECH, V18, pS119, DOI 10.1097/01.bsd.0000127823.54485.3f
· Corea Francesco, 2004, J Stroke Cerebrovasc Dis, V13, P259, DOI 10.1016/j.jstrokecerebrovasdis.2004.08.004
· Freynhagen R, 2006, CURR MED RES OPIN, V22, P1911, DOI 10.1185/030079906X132488
· Gallucci M, 2007, RADIOLOGY, V242, P907, DOI 10.1148/radiol.2423051934
· Gautam S, 2011, PAIN PRACT, V11, P160, DOI 10.1111/j.1533-2500.2010.00409.x
· Gazzeri R, 2007, SPINE, V32, P121
· Ginanneschi F, 2006, SURG NEUROL, V66, P619, DOI 10.1016/j.surneu.2006.01.025
· Giudice GL, 2004, AM J OPHTHALMOL, V138, P175
· Guyatt G, 2006, CHEST, V129, P174, DOI 10.1378/chest.129.1.174
· Kaki AME-YAZ, 2005, REG ANESTH PAIN MED, V30, p422e1
· Koes BW, 1995, PAIN, V63, P279, DOI 10.1016/0304-3959(95)00124-7
· Manchikanti L, 2009, PAIN PHYSICIAN, V12, P699
· Manchikanti L, 2009, PAIN PHYSICIAN, V12, P35
· Moher D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000097
· Muto M, 2004, J NEURORADIOLOGY, V31, P183, DOI 10.1016/S0150-9861(04)96989-1
· Muto M, 1998, INTERV NEURORADIOL, V4, P279
· Muto M, 2008, RADIOL MED, V113, P695, DOI 10.1007/s11547-008-0302-5
· Oder B, 2008, NEURORADIOLOGY, V50, P777, DOI 10.1007/s00234-008-0398-2
· Paoloni M, 2009, SPINE, V34, P1337, DOI 10.1097/BRS.0b013e3181a3c18d
· Postacchini F, 2011, ACTA NEUROCHIR SUPPL, V108, P17, DOI 10.1007/978-3-211-99370-5_4
· Staal JB, 2009, SPINE, V34, P49, DOI 10.1097/BRS.0b013e3181909558
· West S, 2002, EVID REP TECHNOL ASS, V47, P1
· Wu ZQ, 2009, EUR J RADIOL, V72, P499, DOI 10.1016/j.ejrad.2008.07.029
· Xu L, 2009, INTERV NEURORADIOL, V15, P159
· Zambello A, 2006, RIV NEURORADIOL, V5, P123
dc.description.index MEDLINE
hcfmusp.citation.scopus 58
hcfmusp.citation.wos 50


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace



Browse

My Account

Statistics